Brief: Biovica Gets Japanese Patent For Immuno-Oncology
01/07/2026 08:23
BRIEF-Biovica Gets Japanese Patent For Immuno-Oncology July 1 (Reuters) - Biovica International AB BIOVICb.ST:
BIOVICA GRANTED JAPANESE PATENT FOR IMMUNO-ONCOLOGY
GRANTED JAPANESE PATENT FOR TKA USE IN IMMUNE CHECKPOINT INHIBITOR CANCER TREATMENT
Source text: ID:nMFN4X0LMF
Further company coverage: [BIOVICb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))